Skip to content

Clinical trials

Graft vs Host Disease trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Graft vs Host Disease Country / region: China Clear all

48 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20042
20091
20132
20142
20153
20173
20182
20193
20204
20214
20233
20243
202511
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting17
Unknown status15
Completed11
Enrolling by invitation3
Active, not recruiting1
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Peking University People's Hospital6
The First Affiliated Hospital of Soochow University4
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine3
Shanghai Jiao Tong University School of Medicine3
Affiliated Hospital to Academy of Military Medical Sciences2
Fujian Medical University2
Hospital Authority, Hong Kong2
Institute of Hematology & Blood Diseases Hospital, China2
Nanfang Hospital, Southern Medical University2
Novartis Pharmaceuticals2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Graft vs Host Disease48
Recurrence5
Bronchiolitis Obliterans Syndrome4
Leukemia4
Hematologic Neoplasms3
Invasive Fungal Infections2
Leukemia, Myeloid, Acute2
Neoplasm, Residual2
Thalassemia2
Cytomegalovirus Infections1

Trials

Showing 1 to 25 of 48. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.